In the multivariable analysis, NT-proBNP ≥ 855 ng/L emerged as an independent risk factor for SPHF in patients with CAD (adjusted OR 2.87, 95% CI 1.56–5.30, p = 0.001). This evidence concerns the gene NPPB and coronary artery disorder.